Sep. 19, 2019—A new study published by Vanderbilt mechanobiology researchers details a possible solution for fine-tuning inflammation and cellular activity in cardiac recovery – thanks to an antibody initially developed for rheumatoid arthritis.
Feb. 22, 2019—A big-data analysis of patient records at Vanderbilt University has found a link specifically between Celebrex and heart valve calcification.
Nov. 15, 2018—Pulmonary hypertension may be treated by targeting a bone marrow cell that normally promotes the growth of new blood vessels, according to new research by David Merryman.
Jun. 12, 2017—The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.
Feb. 22, 2017—Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs.
Feb. 6, 2017—The 2017 class of Chancellor Faculty Fellows comprises highly accomplished, recently tenured faculty from across the university.
Feb. 3, 2017—David Merryman will study how to treat heart disease using drugs originally developed for rheumatoid arthritis and applying the lessons learned from failed weight loss drugs like Fen-Phen.
Jul. 12, 2016—Five biomedical engineering professors and an electrical engineering and computer science professor are celebrating news about newly approved or resubmitted Research Project Grants (R01) from the Nationals Institutes of Health.